Switch

After rough '12, PHCG looks to inject more life into business

By

An agency bellwether, PHCG is hoping to return to growth after a tame 2012, its CEO said this week.

Study: OTC ads are so over risk info

Study: OTC ads are so over risk info

By

A study of advertising for OTC switches found that presentation of risk information plummeted once the products advertised escaped the purview of the FDA.

Pfizer bets on Rx-to-OTC Nexium switch

Pfizer bets on Rx-to-OTC Nexium switch

By

The drugmaker is paying $250 million to Nexium marketer AstraZeneca for the rights to sell an OTC version, in a deal that may signal a deepening relationship between the two firms.

OTC Lipitor? Good luck with that

OTC Lipitor? Good luck with that

By

Pfizer is reportedly weighing an attempt at an over-the-counter (OTC) switch for Lipitor - a move that could help the company recoup some of its losses when the $11 billion drug loses US exclusivity in November -- but the reception from analysts has been muted so far.

Prevacid OTC switch gets $200 million launch effort

Prevacid OTC switch gets $200 million launch effort

By

Novartis Consumer Health launched OTC Prevacid with a $200 million marketing campaign featuring the tagline: "When you've had it with heartburn."

Email Newsletters